PharmaDiagnostics, a developer of label-free screening technology that does not require specialised instrumentation, has appointed Dr Sylviane Boucharens as director of assay development. She joins from Merck’s MSD site in Newhouse, Scotland, where she was head of global compound repository and in vitro screening.
Boucharens will play a central role in driving the growth of PharmaDiagnostics’ assay product range, and in developing business globally. She worked at Merck from 2000 to 2011. She started her career in the pharmaceutical industry in 1995 when she joined the Immunology Department in the Laboratoires Fournier (Dijon, France).
PharmaDiagnostics appoints director of assay development
Former pharma department head joins Belgian firm
You may also like
Manufacturing
The story of an East-West German company | 150 years of Romaco Kilian
Kilian’s story tells of the rise, fall and resurgence of a Berlin company steeped in tradition, which is now based in Cologne. It is the story of the entrepreneur Fritz Kilian, who turned a small locksmith’s workshop in Berlin into a successful company that is still a leading manufacturer of tablet presses today. It is the story of a visionary whose legacy has endured the test of time and continues to this day
Manufacturing
ystral expands India footprint with new Bangalore facility to support Asian markets
German mixing and process technology specialist ystral has opened a new facility in Bangalore, strengthening its Indian operations and laying the groundwork for a regional service hub supporting fast-growing Asian markets
Manufacturing
Why aseptic processing is critical for microsphere drug manufacturing
As microsphere-based drug delivery systems move from niche innovation to commercial reality, manufacturers face growing pressure to guarantee sterility without compromising product integrity. Aseptic processing has become essential to meeting both regulatory expectations and patient safety requirements